- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human tripeptidyl-peptidase 1
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human tripeptidyl-peptidase 1
| EU orphan designation number: | EU/3/13/1118
|
| Active ingredient: | Recombinant human tripeptidyl-peptidase 1 |
| Indication: | Treatment of neuronal ceroid lipofuscinosis type 2 |
| Sponsor: | BioMarin International Limited
Shanbally, Ringaskiddy, County Cork, Ireland |
| EU Centralised marketing authorisation: | A centralised EU marketing authorisation has been obtained under the name Brineura on 30/05/2017 with the number EU/1/17/1192 |
Public summary of scientific opinion
EPAR
European Commission procedures |


